States file third suit against generics industry

Ben Remaly

11 June 2020

Credit: Shutterstock/SMAK_Photo

A coalition of 51 US states and territories have filed their third sweeping antitrust lawsuit against the generic pharmaceuticals industry, alleging a massive conspiracy to fix prices for topical skin treatments.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Punching up: The Tipline for 2 December 2022
Satire only works when it's directed at the powerful. Federal Trade Commission chair Lina Khan feels the same way about antitrust enforcement. Speaking before the Organisation for Economic Co-operation and Development on Thursday, Khan said enforcers should use their prosecutorial discretion to pick cases that ensure they “punch up, don’t punch down”. Also in Tipline, the UK’s antitrust enforcer wants to stop one of its confidential decisions from being leaked as part of the …
Put me in coach: The Tipline for 1 December 2022
Sing When You're Winning: The Tipline for 30 November 2022

States file third suit against generics industry

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Ben Remaly